TrialIntensive care medicine2019

Extended-duration betrixaban versus shorter-duration enoxaparin for venous thromboembolism prophylaxis in critically ill medical patients: an APEX trial substudy.

Gerald Chi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.